134 related articles for article (PubMed ID: 19373973)
1. Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography.
Kapetanos D; Christodoulou D; Chatzizisi O; Sigounas D; Vasiliou K; Stavropoulou E; Katodritou E; Kokozidis G; Kiriazis G; Kitis G; Tsianos E
Eur J Gastroenterol Hepatol; 2009 May; 21(5):529-33. PubMed ID: 19373973
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis and the Effect of Octreotide Combined with Nonsteroidal Anti-Inflammatory Drugs on Preventing Its Occurrence.
Wang J; Shen Y; Zhong Z; Wu S; Zheng L
Med Sci Monit; 2018 Dec; 24():8964-8969. PubMed ID: 30531679
[TBL] [Abstract][Full Text] [Related]
3. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
4. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
5. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L
Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400
[TBL] [Abstract][Full Text] [Related]
6. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
Binmoeller KF; Harris AG; Dumas R; Grimaldi C; Delmont JP
Gut; 1992 Aug; 33(8):1129-33. PubMed ID: 1383099
[TBL] [Abstract][Full Text] [Related]
7. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
Kapetanos D; Kokozidis G; Christodoulou D; Mistakidis K; Sigounas D; Dimakopoulos K; Kitis G; Tsianos EV
Gastrointest Endosc; 2007 Sep; 66(3):513-8. PubMed ID: 17725940
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
[TBL] [Abstract][Full Text] [Related]
11. [Effect of qingyi decoction in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia].
Liu CG; Leng DY; Liu H
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):607-10. PubMed ID: 19852292
[TBL] [Abstract][Full Text] [Related]
12. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of post-ERCP acute pancreatitis with octreotide].
Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
[TBL] [Abstract][Full Text] [Related]
14. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
Kisli E; Baser M; Aydin M; Guler O
Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
[TBL] [Abstract][Full Text] [Related]
15. Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography.
Chen CC; Wang SS; Lu RH; Lu CC; Chang FY; Lee SD
Pancreas; 2003 May; 26(4):375-80. PubMed ID: 12717271
[TBL] [Abstract][Full Text] [Related]
16. Can octreotide prevent post-ERCP pancreatitis?
Kaya E
Am J Gastroenterol; 2007 Jul; 102(7):1540-1; author reply 1541-2. PubMed ID: 17593165
[No Abstract] [Full Text] [Related]
17. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
Manolakopoulos S; Avgerinos A; Vlachogiannakos J; Armonis A; Viazis N; Papadimitriou N; Mathou N; Stefanidis G; Rekoumis G; Vienna E; Tzourmakliotis D; Raptis SA
Gastrointest Endosc; 2002 Apr; 55(4):470-5. PubMed ID: 11923756
[TBL] [Abstract][Full Text] [Related]
18. Efficacy Versus effectiveness of octreotide in the prophylaxis of post-ERCP pancreatitis.
Andriulli A; Loperfido S
Am J Gastroenterol; 2007 Jul; 102(7):1539. PubMed ID: 17593163
[No Abstract] [Full Text] [Related]
19. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
Foster E; Leung J
Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
[TBL] [Abstract][Full Text] [Related]
20. Octreotide in the prevention of post-ERCP pancreatic injury.
Herszenyi L; Tulassay Z
Am J Gastroenterol; 2007 Jul; 102(7):1539-40. PubMed ID: 17593164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
